Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tibet Naqu Kanghui Pharmaceutical is a pharmaceutical distribution and wholesale company based in the Naqu region of the Tibet Autonomous Region, China. It operates as a wholly-owned subsidiary of Xianyang Kanghui Pharmaceutical, a publicly-traded entity on the Shanghai Stock Exchange. The company specializes in the commercialization and distribution of Chinese patent medicines, chemical drug preparations, and antibiotics. It serves as a strategic regional hub, supporting the parent company's logistics and market expansion efforts in Western China. The firm's operations are integrated with the broader manufacturing and R&D capabilities of the Kanghui Pharmaceutical group, focusing on traditional Chinese medicine and modern pharmaceutical formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tibet Naqu Kanghui Pharmaceutical.